Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion - PubMed (original) (raw)
Comparative Study
. 2007 Dec;50(12):2067-74.
doi: 10.1007/s10350-007-9006-5.
Affiliations
- PMID: 17680311
- DOI: 10.1007/s10350-007-9006-5
Comparative Study
Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion
Michael S Kasparek et al. Dis Colon Rectum. 2007 Dec.
Abstract
Purpose: Symptomatic perianal fistulas impair quality of life in patients with Crohn's disease. Fecal diversion improves symptoms but may impair quality of life. This study was designed to compare long-term quality of life in patients with Crohn's disease with symptomatic perianal fistulas who were treated with or without fecal diversion.
Methods: From 1996 to 2002, perianal fistulas were treated in 116 patients with Crohn's disease. A questionnaire, including four quality of life instruments, was mailed to each patient (Short-Form General Health Survey, Gastrointestinal Quality of Life Index, Cleveland Global Quality of Life Score, Short Inflammatory Bowel Disease Questionnaire).
Results: Questionnaires were returned by 77 of 116 patients (66 percent). Thirty-four of these patients had undergone fecal diversion, whereas 43 had not. Median follow-up was 49 (range, 18-97) months in diverted and 44 (range, 14-98) months in undiverted patients (not significant). In the diverted group, 44 percent complained of Crohn's disease-related symptoms, which was less compared with 79 percent in undiverted patients (P < 0.05). Diverted patients achieved 68 +/- 1 percent of the maximum possible score on the Gastrointestinal Quality of Life Index compared with 60 +/- 2 percent in undiverted patients (mean +/- standard error of the mean; P < 0.001); diverted patients scored better on the subscale "gastrointestinal symptoms" of the Gastrointestinal Quality of Life Index (81 +/- 1 percent vs. 67 +/- 2 percent; P < 0.001). There was no difference in the Short Inflammatory Bowel Disease Questionnaire between diverted and undiverted patients except for the subscale "bowel function" (91 +/- 2 percent vs. 76 +/- 2 percent; P < 0.0001). No difference in quality of life was detected by the Short-Form General Health Survey and Cleveland Global Quality of Life Score.
Conclusions: In the investigated population of patients with Crohn's disease, quality of life seems to be similar or potentially superior in diverted patients suffering from perianal fistulas compared with undiverted patients. A diverting stoma, therefore, may improve quality of life in patients with severe perianal Crohn's disease.
Similar articles
- Endorectal advancement flap: are there predictors of failure?
Mizrahi N, Wexner SD, Zmora O, Da Silva G, Efron J, Weiss EG, Vernava AM 3rd, Nogueras JJ. Mizrahi N, et al. Dis Colon Rectum. 2002 Dec;45(12):1616-21. doi: 10.1097/01.DCR.0000037654.01119.CD. Dis Colon Rectum. 2002. PMID: 12473884 - Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Asteria CR, et al. Scand J Gastroenterol. 2006 Sep;41(9):1064-72. doi: 10.1080/00365520600609941. Scand J Gastroenterol. 2006. PMID: 16938720 - Functional outcome and quality of life after repeat ileal pouch-anal anastomosis for complications of ileoanal surgery.
Baixauli J, Delaney CP, Wu JS, Remzi FH, Lavery IC, Fazio VW. Baixauli J, et al. Dis Colon Rectum. 2004 Jan;47(1):2-11. doi: 10.1007/s10350-003-0003-z. Epub 2004 Jan 2. Dis Colon Rectum. 2004. PMID: 14719144 - Perianal inflammatory conditions in inflammatory bowel disease.
Stein BL, Gordon PH. Stein BL, et al. Curr Opin Gen Surg. 1993:141-6. Curr Opin Gen Surg. 1993. PMID: 7583950 Review. - Perianal Crohn's disease.
ten Cate Hoedemaker HO. ten Cate Hoedemaker HO. Neth J Med. 1994 Aug;45(2):72-5. Neth J Med. 1994. PMID: 7936009 Review.
Cited by
- Stem Cells and Stem Cell-Derived Factors for the Treatment of Inflammatory Bowel Disease with a Particular Focus on Perianal Fistulizing Disease: A Minireview on Future Perspectives.
Lightner AL, Irving PM, Lord GM, Betancourt A. Lightner AL, et al. BioDrugs. 2024 Jul;38(4):527-539. doi: 10.1007/s40259-024-00661-6. Epub 2024 Jun 25. BioDrugs. 2024. PMID: 38914783 Free PMC article. Review. - Translation, cross-cultural adaptation, and psychometric evaluation of the Persian (Farsi) version of the QoLAF (quality of life in patients with anal fistula) questionnaire.
Keramati MR, Yazd SMM, Omidi M, Keshvari A, Shahriarirad S, Shahriarirad R, Ahmadi-Tafti SM, Behboudi B, Kazemeini A, Sahebi L, Fazeli MS. Keramati MR, et al. PLoS One. 2023 Apr 7;18(4):e0277170. doi: 10.1371/journal.pone.0277170. eCollection 2023. PLoS One. 2023. PMID: 37027362 Free PMC article. - The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials.
Wetwittayakhlang P, Al Khoury A, Hahn GD, Lakatos PL. Wetwittayakhlang P, et al. J Clin Med. 2022 May 28;11(11):3045. doi: 10.3390/jcm11113045. J Clin Med. 2022. PMID: 35683433 Free PMC article. Review. - Therapeutic strategies in Crohn's disease in an emergency surgical setting.
Chiarello MM, Pepe G, Fico V, Bianchi V, Tropeano G, Altieri G, Brisinda G. Chiarello MM, et al. World J Gastroenterol. 2022 May 14;28(18):1902-1921. doi: 10.3748/wjg.v28.i18.1902. World J Gastroenterol. 2022. PMID: 35664965 Free PMC article. Review. - Ano-rectovaginal fistula after obstetrical anal sphincter injury: Diverting stoma does not improve the surgical results.
Venara A, Trilling B, Ngoma M, Brochard C, Duchalais E, Siproudhis L, Faucheron JL, de Parades V, Alves A, Cotte E, Ouaissi M, Bridoux V, Corbière L, Heraud J Jr, Ortega-Deballon P, Abo-Alhassan F, Hamel JF. Venara A, et al. Colorectal Dis. 2022 Nov;24(11):1371-1378. doi: 10.1111/codi.16211. Epub 2022 Jun 21. Colorectal Dis. 2022. PMID: 35656842 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical